Koyfin Home > Directory > Health Care > Amphastar Pharma > Total Debt / Equity

Amphastar Pharma Total Debt / Equity Chart (AMPH)

Amphastar Pharma annual/quarterly Total Debt / Equity from 2014 to 2018. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Amphastar Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $14m a -1.53% decrease of 0m year over year
  • Amphastar Pharma Total Debt / Equity for the last 12 months ending December 12, 2018 was $14m a -1.53% decrease of 0m year over year
  • Amphastar Pharma Annual Total Debt / Equity for 2018 was $14m a -6.31% decrease of -1m from 2017
  • Amphastar Pharma Annual Total Debt / Equity for 2017 was $15m a 21.80% increase of 3m from 2016
  • Amphastar Pharma Annual Total Debt / Equity for 2016 was $11m a -21.39% decrease of -2m from 2015
Other Ratios Metrics:
  • Amphastar Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $12m a -1.34% decrease of 0m year over year
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
View Chart On Koyfin

Quarterly AMPH Total Debt / Equity Data

12/2018$14m
09/2018$15m
06/2018$16m
03/2018$14m
12/2017$14m
09/2017$15m
06/2017$14m
03/2017$11m
12/2016$11m
09/2016$13m

Annual AMPH Total Debt / Equity Data

2018$14m
2017$15m
2016$11m
2015$14m
2014$16m
2013$13m